Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
5.26
-1.84 (-25.92%)
At close: Nov 10, 2026, 4:00 PM EST
5.52
+0.26 (4.94%)
Pre-market: Nov 11, 2026, 9:21 AM EST

Exagen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
72.366.5855.6452.5545.5648.3
Revenue Growth
13.67%19.65%5.89%15.33%-5.67%15.07%
Cost of Revenue
29.8327.7822.5323.0924.2120.59
Gross Profit
42.4638.833.1129.4621.3527.71
Selling, General & Admin
49.8446.6241.3747.4352.0244.54
Research & Development
7.156.255.384.879.487.24
Operating Expenses
56.9852.8746.7552.2961.551.78
Operating Income
-14.52-14.07-13.64-22.84-40.15-24.07
Interest Expense
-5-4.32-2.23-2.34-2.45-2.63
Interest & Investment Income
0.290.290.771.520.830.02
Other Non Operating Income (Expenses)
-0.04-----
EBT Excluding Unusual Items
-19.27-18.1-15.1-23.66-41.77-26.68
Impairment of Goodwill
-----5.51-
Asset Writedown
-----0.4-
Other Unusual Items
1.15-1.8----
Pretax Income
-18.12-19.9-15.1-23.66-47.67-26.68
Income Tax Expense
0.050.050.010.03-0.280.18
Net Income
-18.17-19.95-15.12-23.69-47.39-26.85
Net Income to Common
-18.17-19.95-15.12-23.69-47.39-26.85
Net Income Growth
------
Shares Outstanding (Basic)
242218181716
Shares Outstanding (Diluted)
242218181716
Shares Change
19.02%18.43%2.96%3.50%6.95%26.43%
EPS (Basic)
-0.75-0.93-0.83-1.34-2.77-1.68
EPS (Diluted)
-0.76-0.93-0.83-1.34-2.77-1.68
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--14.27-13.79-15.29-36.46-22.64
Free Cash Flow Per Share
--0.66-0.76-0.86-2.13-1.42
Gross Margin
58.74%58.28%59.51%56.05%46.86%57.37%
Operating Margin
-20.08%-21.13%-24.51%-43.46%-88.11%-49.83%
Profit Margin
-25.14%-29.97%-27.16%-45.08%-104.00%-55.59%
Free Cash Flow Margin
--21.43%-24.79%-29.10%-80.03%-46.87%
EBITDA
-12.04-11.95-11.91-20.67-38.59-23.12
EBITDA Margin
-16.65%-17.95%-21.41%-39.33%-84.70%-47.87%
D&A For EBITDA
2.482.121.722.171.560.95
EBIT
-14.52-14.07-13.64-22.84-40.15-24.07
EBIT Margin
-20.08%-21.13%-24.51%-43.46%-88.11%-49.83%
SEC Filings: 10-K · 10-Q